1-20 of 11,300 results for subject:HIV/AIDS
Librarians' tools
- Search time
- 0.494 seconds
- Solr query time
- 0.016 seconds
- Search query
- subject:HIV/AIDS
- We searched for
- subject_t:HIV/AIDS OR subject_t:"Acquired immune deficiency syndrome" OR subject_t:AIDS OR subject_t:HIV OR subject_t:"HIV infection" OR subject_ses:10724
Type
House
Session
More
Year
More
Department
More
Member
More
Primary member
More
Answering member
More
Legislative stage
Legislation
More
Subject
More
Publisher
Lords motion to approve. Amendment to regret debated and withdrawn. Original motion agreed to on question.
Lords motion to approve. Amendment to regret debated and withdrawn. Original motion agreed to on question.
My Lords, we must never lose sight of why we are here to debate these regulations. The infected blood scandal was a catastrophic failure of the state. It is a tragedy measured not only by the pain and suffering of its victims but by the decades it took for the...
My Lords, we must never lose sight of why we are here to debate these regulations. The infected blood scandal was a catastrophic failure of the state. It is a tragedy measured not only by the pain and suffering of its victims but by the decades it took for the...
Moved by
Baroness Brinton
Moved by
Baroness Brinton
My Lords, time is short not just for speakers in this debate, but increasingly so for the remaining victims of infected blood to get justice after one of the biggest ever failures by the British state on record. Curiously enough, all infected blood records are missing in Northern Ireland, for...
My Lords, time is short not just for speakers in this debate, but increasingly so for the remaining victims of infected blood to get justice after one of the biggest ever failures by the British state on record. Curiously enough, all infected blood records are missing in Northern Ireland, for...
My Lords, we must thank the noble Baroness, Lady Brinton, for her introduction to this amendment. Like others, I have had some desperately sad correspondence from widows whose husbands died relatively early after infection. Infection denied them children, some suffered serious discrimination within their family, some find that their husbands...
My Lords, we must thank the noble Baroness, Lady Brinton, for her introduction to this amendment. Like others, I have had some desperately sad correspondence from widows whose husbands died relatively early after infection. Infection denied them children, some suffered serious discrimination within their family, some find that their husbands...
My Lords, it is a great pleasure to follow the noble Baroness, Lady Finlay, and all the speakers in this debate thus far. I continue where she left off, taking a moment to look at the big picture.
We have a huge problem with trust in politics and government in our...
My Lords, it is a great pleasure to follow the noble Baroness, Lady Finlay, and all the speakers in this debate thus far. I continue where she left off, taking a moment to look at the big picture.
We have a huge problem with trust in politics and government in our...
My Lords, my mum Sheila Davies died from liver cancer in 2017 after a long battle with hepatitis. She did not drink, she never smoked, and I think she went out of the country a grand total of three times. In fact, she rarely ventured outside Plymouth, where she worked...
My Lords, my mum Sheila Davies died from liver cancer in 2017 after a long battle with hepatitis. She did not drink, she never smoked, and I think she went out of the country a grand total of three times. In fact, she rarely ventured outside Plymouth, where she worked...
My Lords, it is an honour to follow the noble Baroness. When one hears stories directly like that, they have an impact. I am so sorry for the noble Baroness’s loss. As ever, I have to declare my interest: one of my sister’s twin boys—my nephew, who was a haemophiliac—was...
My Lords, it is an honour to follow the noble Baroness. When one hears stories directly like that, they have an impact. I am so sorry for the noble Baroness’s loss. As ever, I have to declare my interest: one of my sister’s twin boys—my nephew, who was a haemophiliac—was...
My Lords, it is a pleasure to follow the noble Baroness. I want to mention in particular the contribution from the noble Baroness, Lady Davies of Devonport, who set out so powerfully the real-world consequences of this scandal: not just the infections but the stigma that went with them. I...
My Lords, it is a pleasure to follow the noble Baroness. I want to mention in particular the contribution from the noble Baroness, Lady Davies of Devonport, who set out so powerfully the real-world consequences of this scandal: not just the infections but the stigma that went with them. I...
I am deeply conscious of how much knowledge many noble Lords have on this topic, knowledge that has often been tragically accumulated through their own personal experiences and those of their families. I pay tribute to those, both in this House and outside it, who have done so much to...
I am deeply conscious of how much knowledge many noble Lords have on this topic, knowledge that has often been tragically accumulated through their own personal experiences and those of their families. I pay tribute to those, both in this House and outside it, who have done so much to...
My Lords, before I speak to the Motion to approve these regulations and to the regret amendment in the name of the noble Baroness, Lady Brinton, I want to begin by reflecting on the courage and tenacity of all infected and affected victims of the infected blood scandal. They have...
My Lords, before I speak to the Motion to approve these regulations and to the regret amendment in the name of the noble Baroness, Lady Brinton, I want to begin by reflecting on the courage and tenacity of all infected and affected victims of the infected blood scandal. They have...
My Lords, before I start, I put on record that I am in awe of the noble Baroness, Lady Davies, and her speech. I can only imagine how difficult it was for her to stand up and do that. She demonstrates what we have all listened to on many occasions:...
My Lords, before I start, I put on record that I am in awe of the noble Baroness, Lady Davies, and her speech. I can only imagine how difficult it was for her to stand up and do that. She demonstrates what we have all listened to on many occasions:...
I thank the Minister for her introduction to the SI and for the recent meeting. I will ask her many questions. If she cannot answer them all, I will look forward to hearing from her in due course. I have tabled this amendment because of very serious disquiet from infected...
I thank the Minister for her introduction to the SI and for the recent meeting. I will ask her many questions. If she cannot answer them all, I will look forward to hearing from her in due course. I have tabled this amendment because of very serious disquiet from infected...
My Lords, I thank the noble Baroness, Lady Davies of Devonport, for her very moving contribution about her mother’s own experience, reminding us of the consequences of stigma, hidden infections and diseases such as hepatitis not being identified, which meant that she could not be treated. I understand what it...
My Lords, I thank the noble Baroness, Lady Davies of Devonport, for her very moving contribution about her mother’s own experience, reminding us of the consequences of stigma, hidden infections and diseases such as hepatitis not being identified, which meant that she could not be treated. I understand what it...
To ask His Majesty's Government what assessment they have made of the need for funding and support for countries in Africa to treat patients with HIV and cryptococcal meningitis and to make treatments for these diseases available in mainstream healthcare services following cuts to USAID
To ask His Majesty's Government what assessment they have made of the need for funding and support for countries in Africa to treat patients with HIV and cryptococcal meningitis and to make treatments for these diseases available in mainstream healthcare services following cuts to USAID
The Government supports countries across Africa through its investments in multilateral health partners, helping to strengthen health systems and deliver HIV prevention, testing and treatment services, including for opportunistic infections such as cryptococcal meningitis. Through the Global Fund, the Government has supported the introduction and expansion of cryptococcal meningitis treatment in countries where it was previously unavailable or severely constrained.
To ask His Majesty's Government what funding and support they (1) provide, and (2) plan to provide, to countries in Africa to treat patients with HIV and cryptococcal meningitis and to make treatments for these diseases available in mainstream healthcare services following cuts to USAID.
To ask His Majesty's Government what funding and support they (1) provide, and (2) plan to provide, to countries in Africa to treat patients with HIV and cryptococcal meningitis and to make treatments for these diseases available in mainstream healthcare services following cuts to USAID.
The Government supports countries across Africa through its investments in multilateral health partners, helping to strengthen health systems and deliver HIV prevention, testing and treatment services, including for opportunistic infections such as cryptococcal meningitis. Through the Global Fund, the Government has supported the introduction and expansion of cryptococcal meningitis treatment in countries where it was previously unavailable or severely constrained.
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 16 June (HL761), what assessment they have made of the reasons why some HIV-positive patients have been told that they are ineligible for participation in cancer clinical trials.
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 16 June (HL761), what assessment they have made of the reasons why some HIV-positive patients have been told that they are ineligible for participation in cancer clinical trials.
The Department invests £1.8 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR).
Whilst no assessment has been made of the reasons why HIV-patients have been told they are ineligible for participation in cancer trials, the Department is committed to ensuring that all patients, including those with HIV, have access to cutting-edge clinical trials, and innovative, lifesaving treatments through the NIHR. The NIHR does not set participant eligibility criteria for individual clinical trials. These are determined by study sponsors and investigators, subject to regulatory and ethics approval.
The NIHR continues to welcome high quality applications for research into any aspect of human health and care, including HIV and cancer. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to the public and health and care services, value for money, and scientific quality.
The right hon. Gentleman is right to raise that matter, and I will come to it later in my speech, particularly when I discuss the multilateral development bank system, which other Members have raised.
We will prioritise multilateral organisations in the ODA budget, where the international system is required to deliver...
The right hon. Gentleman is right to raise that matter, and I will come to it later in my speech, particularly when I discuss the multilateral development bank system, which other Members have raised.
We will prioritise multilateral organisations in the ODA budget, where the international system is required to deliver...
To ask the Secretary of State for Health and Social Care, a) what steps his Department is taking to ensure that the needs of women are reflected in national and local HIV strategies, policies and decision-making structures, b) what action his Department is taking to address evidence and data gaps...
To ask the Secretary of State for Health and Social Care, a) what steps his Department is taking to ensure that the needs of women are reflected in national and local HIV strategies, policies and decision-making structures, b) what action his Department is taking to address evidence and data gaps...
The HIV Action Plan for England, 2025 to 2030, sets out five core priorities needed to reach our ambition to end new HIV transmissions within England by 2030. One of these priorities is to address stigma and improve the quality of life for people living with HIV, including a national action to ensure the needs of women living with HIV are considered and addressed in future work. The plan also includes an action for local partners to embed HIV awareness into wider women’s health strategies.
Furthermore, the Department is committed to increasing the awareness and understanding of HIV. We are investing £4.8 million from 2026 to 2029 in the newly procured National HIV Prevention England Programme. This programme aims to increase awareness and understanding of HIV and reduce levels of HIV related stigma, particularly for communities disproportionately affected by HIV, such as Black African heterosexual women.
The UK Health Security Agency (UKHSA) will continue to publish HIV surveillance data, new HIV diagnoses, prevention, and outcome indicators, for all populations, including for women. The UKHSA has also committed to work with the voluntary and community sector to publish a specific report on HIV in women that will focus on key trends in HIV diagnoses in women, and highlight any disparities for women in relation to access to testing, pre-exposure prophylaxis, and treatment and care.
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what funding the UK has provided to combat malaria, tuberculosis, and HIV/AIDS in low-income countries.
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what funding the UK has provided to combat malaria, tuberculosis, and HIV/AIDS in low-income countries.
Supporting vaccination and immunisation, preventing and treating disease, and preparing for pandemics and epidemics, are all crucial elements of the UK's global health programmes, working alongside organisations like Gavi, the Vaccine Alliance; the World Health Organisation; the Global Fund; UNAIDS; the Africa Centres for Disease Control and Prevention; and the Coalition for Epidemic Preparedness Innovations.
Our work in those different areas cannot adequately be summarised in the answer to one parliamentary question, but the Hon Member can find regular updates about that work by following the Foreign, Commonwealth & Development Office news feed on GOV.UK, and by continuing to attend our statements, oral questions sessions and urgent question responses in the House.